BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30950860)

  • 1. Epidemiology, Tumor Characteristics, and Survival in Patients With Primary Pancreatic Lymphoma: A Large Population-based Study Using the SEER Database.
    Mukhija D; Nagpal SJS; Sohal DPS
    Am J Clin Oncol; 2019 May; 42(5):454-458. PubMed ID: 30950860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary pancreatic lymphoma: a population-based analysis using the SEER program.
    Mishra MV; Keith SW; Shen X; Bar Ad V; Champ CE; Biswas T
    Am J Clin Oncol; 2013 Feb; 36(1):38-43. PubMed ID: 22134518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Nasopharyngeal Lymphoma in the United States: A Population-Based Analysis of 1119 Cases.
    Han AY; Kuan EC; Alonso JE; Badran KW; St John MA
    Otolaryngol Head Neck Surg; 2017 May; 156(5):870-876. PubMed ID: 28322119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
    Milano AF
    J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
    Smith VA; Camp ER; Lentsch EJ
    Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database.
    Jawad MU; Extein J; Min ES; Scully SP
    Clin Orthop Relat Res; 2009 Nov; 467(11):2939-48. PubMed ID: 19224301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary esophageal non-Hodgkin's lymphoma: demographics, clinical characteristics, histopathologic types, and survival in 179 patients from the SEER program and systematic review of the literature.
    Quiroga-Centeno AC; Bautista-Parada IR; Tapias LF; Gómez-Ochoa SA
    Esophagus; 2021 Oct; 18(4):734-742. PubMed ID: 33880688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
    Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
    Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
    Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
    Yadav S; Sharma P; Zakalik D
    Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters.
    Crippa S; Partelli S; Bassi C; Berardi R; Capelli P; Scarpa A; Zamboni G; Falconi M
    Surgery; 2016 Mar; 159(3):862-71. PubMed ID: 26602841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy.
    Christians KK; Heimler JW; George B; Ritch PS; Erickson BA; Johnston F; Tolat PP; Foley WD; Evans DB; Tsai S
    Surgery; 2016 Mar; 159(3):893-900. PubMed ID: 26602840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer.
    Janz TA; Graboyes EM; Nguyen SA; Ellis MA; Neskey DM; Harruff EE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2019 Feb; 160(2):284-294. PubMed ID: 30129822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.
    Bhatt VR; Giri S; Verma V; Manandhar S; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):373-8. PubMed ID: 27349764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era.
    Howlader N; Mariotto AB; Besson C; Suneja G; Robien K; Younes N; Engels EA
    Cancer; 2017 Sep; 123(17):3326-3334. PubMed ID: 28464214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement.
    Chihara D; Oki Y; Fanale MA; Westin JR; Nastoupil LJ; Neelapu S; Fayad L; Fowler NH; Cheah CY
    Br J Haematol; 2019 Apr; 185(2):334-338. PubMed ID: 29978452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.